tanshinone has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, RJ; Chen, YF; Day, CH; Huang, CY; Lee, NH; Lin, CH; Rajendran, P; Viswanadha, VP; Yang, JJ | 1 |
Li, YS; Wang, J; Wang, ZH | 1 |
2 other study(ies) available for tanshinone and Cardiomyopathy, Hypertrophic Obstructive
Article | Year |
---|---|
Tanshinone IIA Inhibits β-Catenin Nuclear Translocation and IGF-2R Activation via Estrogen Receptors to Suppress Angiotensin II-Induced H9c2 Cardiomyoblast Cell Apoptosis.
Topics: Abietanes; Angiotensin II; Animals; Apoptosis; beta Catenin; Cardiomyopathy, Hypertrophic; Cell Line; Cell Nucleus; Drugs, Chinese Herbal; Humans; Myocytes, Cardiac; Phosphorylation; Protein Transport; Rats; Receptor, IGF Type 2; Receptors, Estrogen; Salvia miltiorrhiza; Signal Transduction | 2017 |
[Effect of tanshinone II A on angiotensin receptor in hypertrophic myocardium of rats with pressure over-loading].
Topics: Abietanes; Animals; Blood Pressure; Calcium; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Female; Humans; Male; Myocardium; Phenanthrenes; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 2008 |